Sense of Hope Alleviates Fatigue in Breast Cancer Survivors

March 22, 2015 updated by: National Taiwan University Hospital

The Sense of Hope Alleviates Fatigue in Breast Cancer Survivors

This study explores the relationship between the sense of hope and fatigue in breast cancer survivors and provides a reference for future planning improvements for breast cancer survivors experiencing fatigue.

Study Overview

Status

Unknown

Conditions

Detailed Description

Breast cancer is an important and escalating issue for females all over the world. Due to the improvement of medical and technological progress, the survival rate of breast cancer patient increases every year. Breast cancer survivors, after the discomforting distress from cancer treatment, will go through treatment-derived physical distress and worry about relapse. As a result the fatigue in breast cancer survivors has not been reduced after primary treatment. Feeling fatigue in a long term will bring mental illness problems ,decrease the quality of life and weaken the will to survive. A sense of hope in the face of fatigue may serve as an important driving force and enhance the survivors' will to survive. This study explores the relationship between the sense of hope and fatigue in breast cancer survivors and provides a reference for future planning improvements for breast cancer survivors experiencing fatigue.

A cross-sectional study design is adopted for this study. The study expects to collect 200 questionnaires from breast cancer survivors through medical centers treating breast cancer and breast cancer patients communities. The questionnaire includes (a) the basic demographic information (b) disease history (c) social support scale; (d) short version multiaxial fatigue syndrome scale; (e) Hearst hope scale.

Answered questionnaires will be input to spreadsheets for further statistical analysis using SPSS 19.0 statistical software packages.

Study Type

Observational

Enrollment (Anticipated)

180

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Taipei, Taiwan, 10002
        • Recruiting
        • National Taiwan University Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

breast cancer survivors,complete chemotherapy and radiotherapy

Description

Inclusion criteria:

  1. diagnosed as a breast cancer patient
  2. complete operation,chemotherapy and radiation therapy
  3. understand the treatment and condition by herself
  4. conscious clear who can speaking Mandarin or: Taiwanese
  5. after consenting , the participant agree to participate orally or write down in the consent form

Exclusion criteria:

  1. Can not speaking Mandarin or Taiwanese
  2. Psychotic or Understanding barriers
  3. refuse verbally or write the Consent Form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Time Perspectives: Cross-Sectional

Cohorts and Interventions

Group / Cohort
Breast cancer survivor
Females finished primary breast cancer treatment including surgical operation, radiation therapy and chemotherapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Multidimensional Fatigue Symptom Inventory-Short Form
Time Frame: Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
A 30-item self-report questionnaire designed to assess the severity, frequency, and daily pattern of fatigue as well as its perceived interference with quality of life.
Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Herth Hope Index
Time Frame: Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
A 12-item self-report questionnaire containing three dimensions: temporality and future, positive readiness and expectancy, and interconnectedness. Tested on family caregivers of terminally ill people and terminally ill persons as well as in community and hospital patients and family members. (Herth, 1990)
Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
The Inventory of Socially Supportive Behaviors
Time Frame: Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy
A 40-item self-report questionnaire designed to assess how often individuals received various forms of assistance during the preceding month, such as directive guidance (e.g., offering advice), nondirective support (e.g., listening and reflecting), positive social exchange (e.g., expressing confidence and encouragement), and tangible assistance (e.g., providing materials or services). (Barrera, Sandler, & Ramsay, 1981).
Baseline measured after the completion of breast cancer surgery, radiation therapy and chemotherapy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan University Hospital

Investigators

  • Principal Investigator: ChunaNG Pei-Hsuan, National Taiwan University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2015

Primary Completion (Anticipated)

July 1, 2015

Study Completion (Anticipated)

July 1, 2015

Study Registration Dates

First Submitted

January 6, 2015

First Submitted That Met QC Criteria

March 18, 2015

First Posted (Estimate)

March 19, 2015

Study Record Updates

Last Update Posted (Estimate)

March 24, 2015

Last Update Submitted That Met QC Criteria

March 22, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 201411051RINB

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Carcinoma of Male Breast

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe